Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice.
D000818:Animals; D000970:Antineoplastic Agents; D006207:Half-Life; D006801:Humans; D007928:Lethal Dose 50; D007939:Leukemia L1210 / Q000188:drug therapy; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009607:Nitrosourea Compounds / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D013311:Streptozocin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; C007028:chlorozotocin; C023479:ICIG 1163; C015747:RFCNU; D013311:Streptozocin